Portfolio Company · Operating Co.
K

Kinvent

backed byEurazeo
CurrentHealthcare
Kinvent
a portfolio company of
Eurazeo
Status on record: Current
Investment year: 2023
PE Firm Index

Who owns Kinvent?

Kinvent is listed as a current portfolio company of Eurazeo on Eurazeo's own portfolio page. Eurazeo has owned Kinvent since 2023, per Eurazeo's portfolio page.

Checking another company? Use the free who owns this company lookup.

Company Snapshot

Kinvent is a Healthcare company. Its owner on record, Eurazeo, is a buyout firm founded in 2001, headquartered in Paris, France, with €35 billion under management. Eurazeo lists 266 companies in the index, 34 of them in Healthcare.

Parent PE firmEurazeo
Ownership statusCurrent
WebsiteNot on record

About the owner

Headquarters
Paris, France
Founded
2001
AUM
€35 billion
Strategy
Buyout, Growth Equity
Sectors
Consumer Goods, Technology, Healthcare
Companies in the index
266

Eurazeo is a leading French private equity firm and investment group that manages a diversified portfolio of over 600 companies.

Read the Eurazeo profile

Questions about Kinvent

Who owns Kinvent?

Kinvent is listed as a current portfolio company of Eurazeo on Eurazeo's own portfolio page. Eurazeo has owned Kinvent since 2023, per Eurazeo's portfolio page.

What sector is Kinvent in?

Kinvent is in Healthcare. Classified from the owner's portfolio label.

Where is Eurazeo headquartered?

Eurazeo is headquartered in Paris, France.

What else does Eurazeo own in Healthcare?

Eurazeo lists 33 other Healthcare companies in the index, including 3P Biopharmaceuticals, Amolyt Pharma, Bioserenity, C2S and Cardiologs Technologies.

Sources

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Kinvent and does not provide investment advice.

Other portfolio companies of Eurazeo

6 of 265 shown

See the full Eurazeo portfolio.

Other Healthcare companies held by Eurazeo

Other Healthcare portfolio companies

Browse PE-backed companies.